An opposite cluster of pathways that are high in non-COVID-19 viral infections and low in COVID-19 positively regulate cell-cell adhesion, cell activation, leukocyte activation, and immune response-activating cell surface receptor signaling, suggesting a less effective immune response in patients with COVID-19. This evidence concerns the gene CD177 and COVID-19.